Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Bhupendra Rawal"'
Autor:
Vinayak Muralidhar, MD, MSc, Nicholas J. Giacalone, MD, Nastaran Milani, MPH, Jonathan D. Schoenfeld, MD, DPhil, MPH, Roy B. Tishler, MD, PhD, Bhupendra Rawal, MS, Danielle N. Margalit, MD, MPH
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 3, Pp 100608- (2021)
Purpose: Many improvements in head and neck cancer (HNC) outcomes are related to optimization of radiation therapy (RT) dose, fractionation, normal-tissue sparing, and technology. However, prior work has shown that the literature of randomized contro
Externí odkaz:
https://doaj.org/article/1354d46e47db4357b10993155ca67744
Autor:
Jiannong Li, Keiryn Bennett, Alexey Stukalov, Bin Fang, Guolin Zhang, Takeshi Yoshida, Isamu Okamoto, Jae‐Young Kim, Lanxi Song, Yun Bai, Xiaoning Qian, Bhupendra Rawal, Michael Schell, Florian Grebien, Georg Winter, Uwe Rix, Steven Eschrich, Jacques Colinge, John Koomen, Giulio Superti‐Furga, Eric B Haura
Publikováno v:
Molecular Systems Biology, Vol 9, Iss 1, Pp 1-19 (2013)
Abstract We hypothesized that elucidating the interactome of epidermal growth factor receptor (EGFR) forms that are mutated in lung cancer, via global analysis of protein–protein interactions, phosphorylation, and systematically perturbing the ensu
Externí odkaz:
https://doaj.org/article/bc792efbcc2c4d1ebd85fd51a06f5c26
Autor:
Joachim Scholz, Richard J Mannion, Daniela E Hord, Robert S Griffin, Bhupendra Rawal, Hui Zheng, Daniel Scoffings, Amanda Phillips, Jianli Guo, Rodney J C Laing, Salahadin Abdi, Isabelle Decosterd, Clifford J Woolf
Publikováno v:
PLoS Medicine, Vol 6, Iss 4, p e1000047 (2009)
BACKGROUND: Adequate pain assessment is critical for evaluating the efficacy of analgesic treatment in clinical practice and during the development of new therapies. Yet the currently used scores of global pain intensity fail to reflect the diversity
Externí odkaz:
https://doaj.org/article/20ee67b40969488884895284fd497959
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
PDF file - 95KB, Supplementary Table S3-A. Human tumor pY proteome. S3-B. Comparison analysis of unique pTyr sites iden_fy from di_erent samples.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::991bcc4786a7c4e9ccf717b3412d1ebc
https://doi.org/10.1158/1078-0432.22451522
https://doi.org/10.1158/1078-0432.22451522
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
PDF file - 104KB, Supplementary Figure 1A-B: PC9GR cells acquired drug resistance to both reversible and irreversible EGFR-TKI. A: PC9 and PC9GR cells were treated for 72 h with increasing concentrations of erlotinib or CL387,785. Data generated by c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07edd3d5fa6425e9291123271d8df6e8
https://doi.org/10.1158/1078-0432.22451540
https://doi.org/10.1158/1078-0432.22451540
Autor:
Dmitry I. Gabrilovich, Ji-Hyun Lee, Bhupendra Rawal, Karen T. Liby, Michael B. Sporn, Scott Antonia, Mayer Fishman, Carlos R. Becerra, Colin Meyer, Matthew J. Cotter, Lily Lu, Cristina Iclozan, Hannah Weber, Je-In Youn, Srinivas Nagaraj
Supplementary Data from Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcf02a6b966399f455c3be3999b58867
https://doi.org/10.1158/1078-0432.22442984
https://doi.org/10.1158/1078-0432.22442984
Autor:
Dmitry I. Gabrilovich, Ji-Hyun Lee, Bhupendra Rawal, Karen T. Liby, Michael B. Sporn, Scott Antonia, Mayer Fishman, Carlos R. Becerra, Colin Meyer, Matthew J. Cotter, Lily Lu, Cristina Iclozan, Hannah Weber, Je-In Youn, Srinivas Nagaraj
Purpose: Myeloid-derived suppressor cells (MDSC) are one of the major factors responsible for immune suppression in cancer. Therefore, it would be important to identify effective therapeutic means to modulate these cells.Experimental Design: We evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::754fcf863b7be5a65ae611d96ca7c4a6
https://doi.org/10.1158/1078-0432.c.6519602.v1
https://doi.org/10.1158/1078-0432.c.6519602.v1
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
PDF file - 139KB, Effects of ligands exposure with or without EGFR-TKI in PC9 and PC9GR cells. A-F: PC9 (A, C, and E) or PC9GR cells (B, D, and F) were incubated for 1 hour in the absence or presence of 100 nM erlotinib (A, C, and E) or afatinib (B,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4edeed900b8dc7c11820b71a014e025f
https://doi.org/10.1158/1078-0432.22451531.v1
https://doi.org/10.1158/1078-0432.22451531.v1
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
PDF file - 54KB, A: Example of peak area (EIC) for EGFR pY 1172. B: Example of peak area (EIC) for MET pY 1234.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c574f49686bb575e00db44016d1abef
https://doi.org/10.1158/1078-0432.22451537
https://doi.org/10.1158/1078-0432.22451537
Autor:
Eric B. Haura, Kazuhiko Nakagawa, Isamu Okamoto, Takafumi Okabe, Kiyoko Shibata, Haruka Yamaguchi, Yume Morita, Michiko Kitano, Ann Y. Chen, Kate J. Fisher, Bhupendra Rawal, John Koomen, Bin Fang, Jiannong Li, Yun Bai, Alex S. Lopez, Matthew A. Smith, Guolin Zhang, Takeshi Yoshida
Purpose: Irreversible EGFR-tyrosine kinase inhibitors (TKI) are thought to be one strategy to overcome EGFR-TKI resistance induced by T790M gatekeeper mutations in non–small cell lung cancer (NSCLC), yet they display limited clinical efficacy. We h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::835d70b5f30c2efd9300b677e85079ab
https://doi.org/10.1158/1078-0432.c.6522212.v1
https://doi.org/10.1158/1078-0432.c.6522212.v1